News

20 May 2009, Cambridge, UK - BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces that its Safety Intelligence Program has been awarded a prestigious "Best Practices" award at the recent Bio-IT World Life Sciences Conference and Expo in Boston.

This award recognises the implementation of the Safety Intelligence Program at AstraZeneca. AstraZeneca partnered with BioWisdom for the Safety Intelligence Program in July 2007, to enhance its ability to predict and understand safety related issues early in the discovery process.  The Safety Intelligence Program applies state-of-the-art technology and methodology to deliver an assertional meta-data solution that semantically harnesses publicly accessible information. The Program is used to support drug safety risk assessment at various stages of the drug discovery process.

BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that AstraZeneca, one of the world's leading pharmaceutical companies, has selected them to apply the Sofia platform to generate a rich vocabulary and assertional meta-data from thousands of AstraZeneca-owned toxicology reports.

The project will make accessible the wealth of historical toxicological observations reported on AstraZeneca development compounds. BioWisdom will help convert documents to machine readable formats, entity extraction and derivation of a detailed lexicon, semantic normalisation using BioWisdom's extensive terminology set, mapping to BioWisdom hierarchies and other standard public vocabularies and the generation of assertional meta-data.

24 February 2009, Cambridge, UK - BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today launches version 2 of their KnowledgeScan service.

KnowledgeScan provides comprehensive and independent assessment of a business issue, and version 2 extends to the use of BioWisdom's powerful intelligence software (Sofia^TM, OmniViz©, SRS^TM) and its range of new assertional meta-data (AMD) products. KnowledgeScan projects are commonly commissioned for gathering chemical, biological or commercial intelligence relevant to in-licensing activities, drug safety assessment, marketing campaigns or assessment of a competitive landscape.

Asterand plc (LSE: ATD), a leading provider of human tissue and services to pharmaceutical companies engaged in drug discovery research, and BioWisdom Ltd, a market leader in delivering healthcare intelligence to the pharmaceutical industry, announce that the Companies have entered into a data syndication agreement to provide value added delivery of Asterand's human gene expression profiles through BioWisdom's intelligence solutions. Terms of the agreement were not disclosed.

16 December 2008, Cambridge, UK - BioWisdom Ltd (BioWisdom), the market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces the availability of the OmniViz Learning Centre and the release of OmniViz 6.0.3.   

 “Software users today are looking for self-paced training materials on the Web.” said Bruce McPherson, VP of Engineering.  “This Learning Centre provides a wealth of resources for new users and experienced users alike. 

6 November 2008, Cambridge, UK - BioWisdom Ltd (BioWisdom), a leader in the provision of healthcare software and healthcare intelligence for the pharmaceutical industry, today announces the release of SRS version 8.3 to academics.

SRS 8.3 provides new functionality, improved user interface and support for the latest hardware and software platforms. It was released to commercial customers in January and has now been made available to academics at a greatly reduced price.

Improvements in the new version include:

21 October 2008, Cambridge, UK - BioWisdom Ltd (BioWisdom), the market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces the release of OmniViz Visualization Software for Patent Specialists.  Patent data are increasingly being used in competitive business and technical intelligence analyses to impact research and business decisions. OmniViz Visualization Software can turn the analysis of thousands of patents into a straightforward and rapid process.

14 October 2008, Cambridge, UK - BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces that Biogemma has renewed its SRS licenses for a further three year term. .

SRS is the world's leading bioinformatics data integration platform, designed to meet the database search and retrieval needs of both Biologists and Bioinformaticians alike.

"We are delighted that Biogemma continue to gain value from our SRS platform and we look forward to working closely with them over the next three years." said Chris Hodkinson, Chief Operating Officer at BioWisdom. "SRS provides a unique system for data integration that is in daily use by over 30,000 people worldwide"

28 April 2008, Cambridge, UK - BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces the release of version 6 of its award-winning OmniViz software and a partnership with CambridgeSoft.

OmniViz visual intelligence software is a complete solution for all data visualization, uniquely supporting the analysis of text, numeric and categorical information. Version 6 incorporates a number of enhancements, such as the ability to identify data columns by attributes and sort them according to these specific attributes. In addition v6 presents new statistical models for analysing subsets of data and enhanced searching and highlighting tools.

6 March 2008, Cambridge, UK - BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) has extended its Collaboration Agreement with OmniViz, Inc., extending J&J PRD's license rights to OmniViz software for information visualization and data mining.

"We are delighted with J&J PRD's decision to continue its relationship with OmniViz" said Michael Stapleton, BioWisdom's CBO. "As our investment in the creation of truly ontology powered applications like OmniViz grows, so does the importance of our strategic collaborators with real world use cases and validation."
OmniViz visual intelligence software is a complete solution for all data visualization, uniquely supporting the analysis of text, numeric and categorical information.